pyrroles has been researched along with No-Reflow Phenomenon in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, GX; Liu, XL; Xu, HP; Zhao, XJ | 1 |
Doevendans, PA; Eefting, FD; Goumans, MJ; Post, MC; Post, S; Rensing, BJ; Stella, PR; van den Branden, BJ; van Es, HW; Wildbergh, TX | 1 |
1 trial(s) available for pyrroles and No-Reflow Phenomenon
Article | Year |
---|---|
Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
Topics: Aged; Atorvastatin; Biomarkers; Chi-Square Distribution; Coronary Circulation; Drug Administration Schedule; Female; Hemodynamics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardium; Netherlands; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pilot Projects; Predictive Value of Tests; Pyrroles; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2012 |
1 other study(ies) available for pyrroles and No-Reflow Phenomenon
Article | Year |
---|---|
Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Coronary Occlusion; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-6; Ligation; Male; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Necrosis; No-Reflow Phenomenon; Pyrroles; Rabbits; Random Allocation | 2014 |